• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人成纤维细胞干扰素基因的位点特异性诱变

Site-specific mutagenesis of the human fibroblast interferon gene.

作者信息

Mark D F, Lu S D, Creasey A A, Yamamoto R, Lin L S

出版信息

Proc Natl Acad Sci U S A. 1984 Sep;81(18):5662-6. doi: 10.1073/pnas.81.18.5662.

DOI:10.1073/pnas.81.18.5662
PMID:6091102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC391770/
Abstract

Human fibroblast interferon has three cysteine residues, located at amino acid positions 17, 31, and 141. Using the technique of site-specific mutagenesis with a synthetic oligonucleotide primer, we changed the codon for cysteine-17 to a codon for serine. The resulting interferon, IFN-beta Ser-17, retains the antiviral, natural killer cell activation, and antiproliferative activities of native fibroblast interferon. The purified IFN-beta Ser-17 protein has an antiviral specific activity of 2 X 10(8) units/mg, similar to that of purified native fibroblast interferon. In addition, the purified protein is stable to long-term storage at -70 degrees C.

摘要

人成纤维细胞干扰素含有三个半胱氨酸残基,位于氨基酸位置17、31和141处。我们使用合成寡核苷酸引物进行定点诱变技术,将半胱氨酸-17的密码子替换为丝氨酸的密码子。由此产生的干扰素,即IFN-β Ser-17,保留了天然成纤维细胞干扰素的抗病毒、自然杀伤细胞激活和抗增殖活性。纯化的IFN-β Ser-17蛋白具有2×10⁸单位/毫克的抗病毒比活性,与纯化的天然成纤维细胞干扰素相似。此外,纯化后的蛋白在-70℃下长期储存稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d91/391770/b21d4af3d386/pnas00619-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d91/391770/b21d4af3d386/pnas00619-0049-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d91/391770/b21d4af3d386/pnas00619-0049-a.jpg

相似文献

1
Site-specific mutagenesis of the human fibroblast interferon gene.人成纤维细胞干扰素基因的位点特异性诱变
Proc Natl Acad Sci U S A. 1984 Sep;81(18):5662-6. doi: 10.1073/pnas.81.18.5662.
2
Alpha-interferon structure and natural killer cell stimulatory activity.α-干扰素的结构与自然杀伤细胞刺激活性。
Cancer Res. 1990 Sep 1;50(17):5328-32.
3
Single amino acid changes that render human IFN-alpha 2 biologically active on mouse cells.
EMBO J. 1987 Mar;6(3):591-8. doi: 10.1002/j.1460-2075.1987.tb04795.x.
4
Extracellular production of mouse interferon beta by the Bacillus subtilis alpha-amylase secretion vectors: antiviral activity and deduced NH2-terminal amino acid sequences of the secreted proteins.枯草芽孢杆菌α-淀粉酶分泌载体在胞外产生小鼠干扰素β:分泌蛋白的抗病毒活性及推导的NH2-末端氨基酸序列
Intervirology. 1991;32(4):216-27. doi: 10.1159/000150203.
5
Pleiotropic activities of human interferons are mediated by multiple response pathways.人类干扰素的多效性活动是由多种反应途径介导的。
Proc Natl Acad Sci U S A. 1984 Jan;81(1):170-4. doi: 10.1073/pnas.81.1.170.
6
Single amino acid substitutions at conserved residues of human interferon-alpha can effect antiviral specific activity.人干扰素α保守残基处的单个氨基酸替换可影响抗病毒比活性。
Biochem Int. 1985 Sep;11(3):301-9.
7
Biologic activity in a fragment of recombinant human interferon alpha.重组人干扰素α片段中的生物活性。
Proc Natl Acad Sci U S A. 1984 Feb;81(4):1045-7. doi: 10.1073/pnas.81.4.1045.
8
Structure-function analysis of mouse interferon alpha species: MuIFN-alpha 10, a subspecies with low antiviral activity.小鼠α干扰素亚型的结构-功能分析:MuIFN-α 10,一种具有低抗病毒活性的亚型
J Gen Virol. 1988 Jan;69 ( Pt 1):67-75. doi: 10.1099/0022-1317-69-1-67.
9
A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.干扰素Con1与天然重组α干扰素的比较:抗病毒、抗增殖及诱导自然杀伤细胞活性
J Interferon Res. 1992 Feb;12(1):55-9. doi: 10.1089/jir.1992.12.55.
10
Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificity.杂交白细胞干扰素的羧基末端区域影响抗病毒特异性。
DNA. 1982;1(3):223-30. doi: 10.1089/dna.1.1982.1.223.

引用本文的文献

1
Implications of glycosylation for the development of selected cytokines and their derivatives for medical use.糖基化对选定细胞因子及其衍生物在医学用途方面的发展的影响。
Biotechnol Adv. 2024 Dec;77:108467. doi: 10.1016/j.biotechadv.2024.108467. Epub 2024 Oct 22.
2
Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress.免疫调节细胞因子疗法的工程策略——挑战与临床进展
Adv Ther (Weinh). 2021 Aug;4(8). doi: 10.1002/adtp.202100035. Epub 2021 Apr 2.
3
Optimization of medium composition to increase the expression of recombinant human interferon-β using the Plackett-Burman and central composite design in SE1.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding.通过定点诱变重新设计酶结构:酪氨酰tRNA合成酶与ATP结合
Nature. 1982 Oct 21;299(5885):756-8. doi: 10.1038/299756a0.
3
Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia.功能性人类抑制性tRNA基因的构建:一种β地中海贫血基因治疗方法
使用Plackett-Burman和中心复合设计优化培养基成分以提高重组人干扰素-β在SE1中的表达
3 Biotech. 2021 May;11(5):226. doi: 10.1007/s13205-021-02772-1. Epub 2021 Apr 19.
4
Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives.新冠疫情时代多发性硬化症免疫疗法的潜在风险与益处:临床与免疫学视角
Neurotherapeutics. 2021 Jan;18(1):244-251. doi: 10.1007/s13311-021-01008-7. Epub 2021 Feb 2.
5
Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature.神经免疫治疗在 COVID-19 时代——在文献中寻找共识。
Nat Rev Neurol. 2020 Sep;16(9):493-505. doi: 10.1038/s41582-020-0385-8. Epub 2020 Jul 8.
6
Efficient production of human interferon beta in the white of eggs from ovalbumin gene-targeted hens.高效生产人干扰素-β的卵清白蛋白基因靶向母鸡。
Sci Rep. 2018 Jul 5;8(1):10203. doi: 10.1038/s41598-018-28438-2.
7
Novel pegylated interferon-β as strong suppressor of the malignant ascites in a peritoneal metastasis model of human cancer.新型聚乙二醇化干扰素-β在人癌腹膜转移模型中对恶性腹水具有强大的抑制作用。
Cancer Sci. 2017 Apr;108(4):581-589. doi: 10.1111/cas.13176. Epub 2017 Apr 20.
8
Production and characterization of neurosecretory protein GM using Escherichia coli and Chinese Hamster Ovary cells.利用大肠杆菌和中国仓鼠卵巢细胞生产神经分泌蛋白GM并对其进行表征。
FEBS Open Bio. 2015 Oct 22;5:844-51. doi: 10.1016/j.fob.2015.10.002. eCollection 2015.
9
Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties.糖基工程化干扰素-β 1a 可改善其物理化学性质和药代动力学特性。
PLoS One. 2014 May 23;9(5):e96967. doi: 10.1371/journal.pone.0096967. eCollection 2014.
10
Overexpression of Recombinant Human Beta Interferon (rhINF-β) in Periplasmic Space of Escherichia coli.重组人β干扰素(rhINF-β)在大肠杆菌周质空间中的过表达。
Iran J Pharm Res. 2014 Winter;13(Suppl):151-60.
Nature. 1982 Apr 8;296(5857):537-40. doi: 10.1038/296537a0.
4
Structure and expression of a cloned cDNA for mouse interferon-beta.小鼠β干扰素克隆cDNA的结构与表达
J Biol Chem. 1983 Aug 10;258(15):9522-9.
5
Properties of a human alpha-interferon purified from E. coli extracts.从大肠杆菌提取物中纯化得到的人α干扰素的特性。
J Interferon Res. 1981;1(3):381-90. doi: 10.1089/jir.1981.1.381.
6
Virus yield-reduction assay for interferon by titration of infectious virus.通过滴定感染性病毒进行干扰素的病毒产量降低试验。
Methods Enzymol. 1981;78(Pt A):346-51. doi: 10.1016/0076-6879(81)78140-0.
7
Purification and molecular characterization of human fibroblast interferon.人成纤维细胞干扰素的纯化及分子特性分析
Arch Biochem Biophys. 1981 Feb;206(2):432-50. doi: 10.1016/0003-9861(81)90111-9.
8
Expression of the human fibroblast interferon gene in Escherichia coli.人成纤维细胞干扰素基因在大肠杆菌中的表达。
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5230-3. doi: 10.1073/pnas.77.9.5230.
9
Synthesis of human fibroblast interferon by E. coli.大肠杆菌合成人成纤维细胞干扰素。
Nucleic Acids Res. 1980 Sep 25;8(18):4057-74. doi: 10.1093/nar/8.18.4057.
10
Expression of human fibroblast interferon gene in Escherichia coli.人成纤维细胞干扰素基因在大肠杆菌中的表达。
Nature. 1980 Sep 18;287(5779):193-7. doi: 10.1038/287193a0.